Literature DB >> 10836144

The role of Rho in G protein-coupled receptor signal transduction.

V P Sah1, T M Seasholtz, S A Sagi, J H Brown.   

Abstract

Low molecular weight G proteins of the Rho subfamily are regulators of actin cytoskeletal organization. In contrast to the heterotrimeric G proteins, the small GTPases are not directly activated through ligand binding to G protein-coupled receptors (GPCRs). However, a subset of GPCRs, including those for lysophosphatidic acid and thrombin, induce stress fibers, focal adhesions, and cell rounding through Rho-dependent pathways. C3 exoenzyme has been a useful tool for demonstrating Rho involvement in these and other responses, including Ca2+ sensitization of smooth muscle contraction, cell migration, transformation, and serum response element-mediated gene expression. Most of the GPCRs that induce Rho-dependent responses can activate Gq, but this is not a sufficient signal. Recent data demonstrate that G alpha 12/13 can induce Rho-dependent responses. Furthermore, G alpha 12/13 can bind and activate Rho-specific guanine nucleotide exchange factors, providing a mechanism by which GPCRs that couple to G alpha 12/13 could activate Rho and its downstream responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836144     DOI: 10.1146/annurev.pharmtox.40.1.459

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  64 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

2.  Physical and functional interactions of Galphaq with Rho and its exchange factors.

Authors:  S A Sagi; T M Seasholtz; M Kobiashvili; B A Wilson; D Toksoz; J H Brown
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

3.  Rho family GTP binding proteins are involved in the regulatory volume decrease process in NIH3T3 mouse fibroblasts.

Authors:  Stine F Pedersen; Kristine H Beisner; Charlotte Hougaard; Berthe M Willumsen; Ian H Lambert; Else K Hoffmann
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

4.  Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases.

Authors:  Junji Yamauchi; Jonah R Chan; Eric M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

Review 5.  Pasteurella multocida toxin as a tool for studying Gq signal transduction.

Authors:  B A Wilson; M Ho
Journal:  Rev Physiol Biochem Pharmacol       Date:  2004-09-29       Impact factor: 5.545

6.  RhoA-mediated potential regulation of blood-tumor barrier permeability by bradykinin.

Authors:  Teng Ma; Yixue Xue
Journal:  J Mol Neurosci       Date:  2010-04-06       Impact factor: 3.444

7.  A new approach to producing functional G alpha subunits yields the activated and deactivated structures of G alpha(12/13) proteins.

Authors:  Barry Kreutz; Douglas M Yau; Mark R Nance; Shihori Tanabe; John J G Tesmer; Tohru Kozasa
Journal:  Biochemistry       Date:  2006-01-10       Impact factor: 3.162

8.  TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.

Authors:  Jun Xu; Yun-Ju Lai; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

9.  Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.

Authors:  Dezheng Zhao; Sabina Kuhnt-Moore; Huiyan Zeng; Amy Pan; Jack S Wu; Simos Simeonidis; Mary P Moyer; Charalabos Pothoulakis
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

10.  Antibody-induced acetylcholine receptor clusters inhabit liquid-ordered and liquid-disordered domains.

Authors:  Constanza B Kamerbeek; Virginia Borroni; María F Pediconi; Satoshi B Sato; Toshihide Kobayashi; Francisco J Barrantes
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.